Suppr超能文献

越南出现了质粒介导的 cfr 介导的利奈唑胺耐药葡萄球菌。

The emergence of plasmid-borne cfr-mediated linezolid resistant-staphylococci in Vietnam.

机构信息

Biotechnology Center of Ho Chi Minh City, Viet Nam.

University of Science, Vietnam National University HCMC, Viet Nam.

出版信息

J Glob Antimicrob Resist. 2020 Sep;22:462-465. doi: 10.1016/j.jgar.2020.04.008. Epub 2020 Apr 27.

Abstract

OBJECTIVES

Linezolid is one of the last resort antibiotics effectively used in the treatment of infections caused by multidrug-resistant Gram-positive bacteria. Recent outbreaks of Linezolid resistance have been the great concern worldwide, while many countries have not experienced it. In this work, we aimed to evaluate the existence of linezolid resistance and further clarify potential resistance mechanism(s) in staphylococcal isolates obtained from the hospital in Vietnam, a country in which linezolid resistance had not been previously detected.

METHODS

Seventy staphylococcal clinical isolates including MRSA (n=63) and methicillin-resistant coagulase-negative staphylococci (MRCNS, n=7) were collected and analyzed for linezolid resistance. Linezolid-resistant isolates were submitted for whole genome sequencing to search for the resistance determinants.

RESULTS

We identified two coagulase-negative staphylococcal isolates that were resistant to linezolid. Whole genome sequencing revealed several alterations in the 23S rRNA and L3, L17, L22, L24, L30 ribosomal proteins. Importantly, both isolates harbour the chloramphenicol/florfenicol resistance (cfr) gene on a plasmid. The plasmid was closely identical to the pLRSA417 plasmid that was originally reported in China.

CONCLUSIONS

To the best of our knowledge, this is the first report of cfr-mediated linezolid resistance in clinically isolated staphylococci in Vietnam. We suggest that adequate surveillance is necessary to monitor the dissemination of linezolid resistance among staphylococcal species and other important pathogens.

摘要

目的

利奈唑胺是一种最后手段的抗生素,有效用于治疗耐多药革兰阳性菌引起的感染。利奈唑胺耐药性的最近爆发引起了全世界的极大关注,而许多国家尚未经历过这种情况。在这项工作中,我们旨在评估利奈唑胺耐药性的存在,并进一步阐明从越南医院获得的葡萄球菌分离株中潜在的耐药机制,该国以前未检测到利奈唑胺耐药性。

方法

收集了 70 株葡萄球菌临床分离株,包括耐甲氧西林金黄色葡萄球菌(MRSA,n=63)和耐甲氧西林凝固酶阴性葡萄球菌(MRCNS,n=7),并对利奈唑胺耐药性进行了分析。将利奈唑胺耐药分离株进行全基因组测序,以寻找耐药决定因素。

结果

我们鉴定出两株凝固酶阴性葡萄球菌对利奈唑胺耐药。全基因组测序显示 23S rRNA 和 L3、L17、L22、L24、L30 核糖体蛋白发生了几种改变。重要的是,这两个分离株都在质粒上携带氯霉素/氟苯尼考耐药(cfr)基因。该质粒与最初在中国报道的 pLRSA417 质粒非常相似。

结论

据我们所知,这是越南临床分离的葡萄球菌中 cfr 介导的利奈唑胺耐药的首次报告。我们建议有必要进行充分的监测,以监测利奈唑胺耐药性在葡萄球菌和其他重要病原体中的传播。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验